Fabian E Ortega

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Listeria Monocytogenes

Positive Breast Cancer

Endoplasmic Reticulum

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics 23 (3) (2024)
Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon
Palazestrant (OP-1250), a Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination. Molecular cancer therapeutics (2023)
Fabian E Ortega, Elena F Koslover, Julie A Theriot
Listeria monocytogenes cell-to-cell spread in epithelia is heterogeneous and dominated by rare pioneer bacteria. eLife 8 (2019)
Cristina Faralla, Effie E Bastounis, Fabian E Ortega, Samuel H Light, Gabrielle Rizzuto, Lei Gao, Denise K Marciano, Salvatore Nocadello, Wayne F Anderson, Jennifer R Robbins, Julie A Theriot, Anna I Bakardjiev
Listeria monocytogenes InlP interacts with afadin and facilitates basement membrane crossing. PLoS pathogens 14 (5) (2018)